Hisamitsu Pharmaceutical Co's total assets for Q2 2024 were ¥350.48B, an increase of 3.43% from the previous quarter. HTSUF total liabilities were ¥74.55B for the fiscal quarter, a 3.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.